Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up

Petar Mamula, Jonathan E. Markowitz, Louis J. Cohen, Daniel von Allmen, Robert N. Baldassano

Research output: Contribution to journalArticlepeer-review

74 Scopus citations


The role of infliximab in treating pediatric ulcerative colitis (UC) is not defined. The authors previously have described their experience with the open label use of infliximab in nine children with moderate to severe UC. The aim of this study was to describe the outcome of these patients after a minimum 2-year follow-up and to describe the responses of eight additional patients to this medication.

Original languageEnglish
Pages (from-to)298-301
Number of pages4
JournalJournal of Pediatric Gastroenterology and Nutrition
Issue number3
StatePublished - Mar 2004
Externally publishedYes


  • Infliximab
  • Pediatric
  • Ulcerative colitis


Dive into the research topics of 'Infliximab in Pediatric Ulcerative Colitis: Two-year Follow-up'. Together they form a unique fingerprint.

Cite this